InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Hull Hans, Directeur Commercial. Director active across 1 companies, notably Pliant Therapeutics, INC.. Aggregated, 2 filings have been recorded. The latest transaction was disclosed on 26 May 2021 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€7,6774,500 shares@ €1.7060.010% mcap100.0% of flow
Common Stock
SEC:0001209191-21-036690·
€7,6774,500 shares@ €1.7060.010% mcap50.0% of flow
Common Stock
SEC:0001209191-21-036690:0·
2 of 2 declarations
About Hull Hans
Hans Hull is the Chief Business Officer at PLIANT THERAPEUTICS, INC. He is responsible for the company's business strategy, contributing to expansion and innovation. His expertise is crucial for developing new market opportunities.
